Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis
PLOS ONE · 12.12.2024 · 19 (12) · e0310900
DOI: 10.1371/journal.pone.0310900 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 12.12.2024. Verfasst von Sung Ryul Shim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Konyang University College of Medicine, Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Accidental Falls, Gait, Neurodegenerative Diseases, Rivastigmine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background & aims Gait disturbances are commonly observed in patients with neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and higher-level gait disorders, which are associated with cholinergic deficits. We conducted a systematic review and meta-analysis to investigate the effects of rivastigmine on improvement in gait.
Methods
A comprehensive literature search was conducted using Medical Subject Heading (MeSH) terms and text keywords related to gait and falls after rivastigmine treatment for neurodegenerative disorders. The intervention (rivastigmine), comparison (control or no treatment), and outcomes of improvement in gait speed and fall were assessed from database inception to April 2024. References and collected data were meticulously reviewed to ensure the integrity of the included studies. Standardized mean differences (SMDs) and Hedges’g, along with their 95% confidence intervals (Cls), were calculated for gait speed and number of falls.
Results
A total of 222 articles were identified during the initial search across different electronic databases, 50 including PubMed (n = 23), Cochrane (n = 19), Embase (n = 139), Scopus (n = 38), and a manual search (n = 3). Finally, we conducted a systematic review and meta-analysis focusing on the final four studies, encompassing 286 participants. The pooled SMD for the overall gait speed without a comparison group was 0.761 (95% CI: −1.165 to 2.688), indicating no significant improvement in gait speed. For the overall number of falls between the rivastigmine treatment and control groups, the pooled SMD was −0.366 (95% CI: −0.650 to −0.083). A statistically significant reduction in the number of falls was observed in the rivastigmine group than in the control group.
Conclusion
Rivastigmine treatment in patients with neurodegenerative disorders tend to improve gait speed and significantly reduces fall incidence. Given the limited efficacy of current treatments for gait disturbances and falls, dual cholinesterase inhibitors like rivastigmine could be a promising therapeutic option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Informatics, Konyang University College of Medicine, Daejeon, Republic of Korea.
- Department of Otorhinolaryngology-Head and Neck Surgery, Konyang University College of Medicine, Daejeon, Republic of Korea.
- Department of Neurology, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.
- Department of Rehabilitation Medicine, Konyang University College of Medicine, Daejeon, Republic of Korea.
- Department of Neurology, Konyang University College of Medicine, Daejeon, Republic of Korea.
- Myunggok Medical Research Institute, Konyang University College of Medicine, Daejeon, Republic of Korea.
ORCID-Profile: Jong-Yeup Kim, Seon-Min Lee
Zitieren
APA
Shim, S. R., Kim, J. Y., Kwon, K. Y., Shin, J., Lee, Y., & Lee, S. M. (2024). Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis. PLOS ONE, 19(12), e0310900. https://doi.org/10.1371/journal.pone.0310900
Vancouver
Shim SR, Kim JY, Kwon KY, Shin J, Lee Y, Lee SM. Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis. PLOS ONE. 2024;19(12):e0310900. doi:10.1371/journal.pone.0310900
BibTeX
@article{Shim2024,
author = {Shim, Sung Ryul and Kim, Jong-Yeup and Kwon, Kyum-Yil and Shin, Jieun and Lee, Yungjin and Lee, Seon-Min},
title = {Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {12},
pages = {e0310900},
doi = {10.1371/journal.pone.0310900}
}
EUVIMED